Latest filing published 13 Mar 2026 for Xenon Pharmaceuticals Inc., €64k.
Filing timeline
BuySaleInsider track record
Andrea DiFabio: trading record in brief
This profile gathers the share dealings of Andrea DiFabio across 2 companies, led by Bioverativ Inc. and Xenon Pharmaceuticals Inc. In total, 18 filings cover trades dated from 28 February 2017 to 13 March 2026.
The open-market record consists of 2 sales worth €199k, with no purchase. Outside the open market, there are 12 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 13 March 2026, reports an open-market sale of €64k in Xenon Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrea DiFabio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,342 shares@ US$55.2332.3% of flowCommon SharesSEC:0001193125-26-106726:1
- 3,750 sharesCommon SharesSEC:0001193125-26-106726:0
- 2,607 shares@ US$60.1167.7% of flowCommon SharesSEC:0001193125-26-102667:1
- 7,500 sharesCommon SharesSEC:0001193125-26-102667:0
- 30,600.2 sharesCommon StockSEC:0001127602-18-010654:0
- 2,011 shares@ US$104.3028.6% of flowCommon StockSEC:0001127602-18-008437:0
- 917 shares@ US$104.7413.0% of flowCommon StockSEC:0001127602-18-008437:1
- 3,744 shares0Common StockSEC:0001127602-18-006414:0
- 1,136 shares@ US$103.5215.9% of flowCommon StockSEC:0001127602-18-006414:1
- 636 shares@ US$53.654.9% of flowCommon StockSEC:0001127602-17-031184:0
- 1,155 shares@ US$43.427.9% of flowCommon StockSEC:0001127602-17-009670:1
- 368 shares@ US$49.562.9% of flowCommon StockSEC:0001127602-17-009670:2
- 285 shares@ US$49.562.2% of flowCommon StockSEC:0001127602-17-009670:5
- 918 shares@ US$47.766.9% of flowCommon StockSEC:0001127602-17-009670:6
- 718 shares@ US$43.424.9% of flowCommon StockSEC:0001127602-17-009670:7
- 35,019 shares0Common StockSEC:0001127602-17-009670:0
- 532 shares@ US$43.423.7% of flowCommon StockSEC:0001127602-17-009670:4
- 1,191 shares@ US$47.769.0% of flowCommon StockSEC:0001127602-17-009670:3
18 of 18 declarations
